LAS VEGAS, NV / ACCESSWIRE / June 22, 2017 / CEO of Costas, Inc. Mr. Clifford Redekop is pleased to announce the addition of Dr. Stephen L. Gomes to the Costas Inc. board of directors. Mr. Redekop says, "Dr. Gomes will add significant expertise in our planning and execution of building the Costas brand. Our push is to acquire digital companies that rely on or primarily operate with FINTech, and Dr. Gomes' ability to do analysis on our acquisition targets will ensure Costas is making moves with the best advice in the market."
- Dr. Gomes' professional career has been focused primarily on the formation, leadership and management of international business strategic alliances and cross cultural business strategies. This assumes a deep understanding of what counts as strategic in an enterprise versus what is only short term tactical in nature.
- Dr. Gomes earned a Ph.D. in Public Management and International Relations from the University of Pittsburgh Graduate School of Public and International Affairs funded on a NASA Ph.D. fellowship. His early career was in executive management positions with large international companies with senior responsibility for contracts with government leaders, royal family members and large corporations such as ARAMCO in Saudi Arabia and Mitsubishi Corporation in Japan. His executive duties have included extended assignments in France, Greece, China, Malaysia, Japan, Saudi Arabia, Kuwait, Russia, Brazil and Holland.
Included in his work history of more than 30 strategic alliance and joint venture agreements are the following:
- developed and negotiated more than 15 public/private high-tech co-development strategic alliance agreements between major U.S. companies, universities and the Federal Research Labs with a total value of $160 million;
- five major supplier alliance agreements with values up to $15,000,000 for two major U.S. Oil Companies;
- long term real estate asset management outsourcing alliance agreement with values up to $1 billion in real estate asset value;
- set up multi-party manufacturing alliance with major big three air bag manufacturing firm;
- assisted IBM to develop five outsourcing alliances with technology providers for the master Information Technology health care system contract for the
Province of Alberta;
- supported negotiations and alliance discussions on behalf of 15 U.S. corporations and multinational companies with combined assets up to $15 million for each agreement.
- Currently, Dr. Gomes manages Gomes & Company, which is a boutique executive consulting firm engaged in a broad range of domestic and international multi-party consulting assignments mostly focused on high tech and finance start-ups, joint ventures planning, action planning workshops, organization problem solving and specialized business plan strategy and development. For several years, his firm's main clients were Fortune 500 companies working with the Warren Company based in Providence, Rhode Island. While in San Francisco, Dr. Gomes managed the West Coast operation where he was responsible for assisting large corporate clients in the creation and implementation of strategic business alliances, facilitated technology transfer, the formation of technology co-development alliances, R&D consortia and joint ventures. He was instrumental in helping to bring in one of the firm's largest clients, Andersen Consulting which became Accenture Corporation. Before being retained by the Warren Company, he was CEO of American Technology Initiative (Am Tech), a non-profit corporation, co-founded by NASA and the private sector, based in Silicon Valley dedicated to the implementation of public-private technology development alliances and partnerships between universities, federal research labs and the private sector. Clients included NASA, Los Alamos, Cal-Tech, Boeing, and Sandia labs.
- Dr. Gomes has also taught MBA Master's degree courses in Start up Management, Technology Commercialization and Strategic Alliance and Joint Venture Practices (Oregon Graduate Institute - now OHSU, State University of New York (SUNY-Stony Brook - Korea Campus) and Maastricht School of Management, Maastricht, Netherlands).
- Dr. Gomes is active in a number of non-profit activities and boards. He has served in the past as a director on the National Board of Advisers for the Peace Corps and the Virginia Satir Foundation. He currently is also a fellow of the Innovation Creativity and Capital Institute ( IC2 ) of the University of Texas at Austin, which met in April 2017 in Austin. This is a group of international business thought leaders and professors who participate in the University of Texas Business School annual leadership strategy conference sessions by invitation only. Finally Dr. Gomes is an aviation enthusiast and has been flying airplanes since he was 12 years old. At one time he was the youngest pilot in the United States. Howard Hughes hired him for his aviation expertise and knowledge of local Las Vegas flying conditions and politics. At the age of 25, Gomes was put in charge of planning a new $650 million airport for Las Vegas to replace McCarran Field which was to be built at Howard Hughes expense and turned over to Las Vegas at his cost. Later in his career Dr. Gomes used that experience with two other companies to participate in the planning of 12 major new international airports around the globe over a 20 year period.
About COSTAS (CSSI): http://www.otcmarkets.com/stock/CSSI/profile
COSTAS INC. is a publicly traded company on the OTC Markets under the symbol 'CSSI'. Costas Inc. invests in early stage Digital Currency projects. We believe strongly in the growth of Distributed Asset Technology and its integration into Financial Technologies (FINTech. Distributed Networks are the next massive internet investment market, as social media was 10 years ago. Costas Inc. strongly believes that a Distributed Asset Technology product will be the next Facebook or Twitter. The current US market of FINTech is approximately $1.24 Trillion.
FORWARD LOOKING STATEMENTS:
This press release and the statements of representatives of Costas, Inc. (the "Company") related thereto contain, or may contain, among other things, "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact included herein are "forward-looking statements," including any other statements of non-historical information. These forward-looking statements are subject to significant known and unknown risks and uncertainties and are often identified by the use of forward-looking terminology such as "guidance," "projects," "may," "could," "would," "should," "believes," "expects," "anticipates," "estimates," "intends," "plans," "ultimately" or similar expressions. All forward-looking statements involve material assumptions, risks and uncertainties, and the expectations contained in such statements may prove to be incorrect. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results (including, without limitation, Costas' ability to advance its business, generate revenue and profit and operate as a public company) could differ materially from those stated or anticipated in these forward-looking statements as a result of a variety of factors, including factors and risks discussed in the periodic reports that the Company files with OTC Markets (Pink Sheets). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. The Company undertakes no duty to update these forward-looking statements except as required by law.
For further information contact:
Costas Corporate Phone Number
SOURCE: Costas, Inc.